Has Brian Jackson received payments from drug or device companies?

Yes. Drug and device makers reported $477,142 in general payments to Brian Jackson across 182 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brian Jackson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brian Jackson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brian Jackson

General Practice · Utica, NYNPI 1528132784

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $421,112 of the $477,142 with a category attached, or 88.3%. Implant Direct Sybron International LLC accounts for 66.2% of it on its own, with 14 other manufacturers making up the rest. Among general practice clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$477,142in general payments, 2019–2025

Across 182 payments — averaging $2621.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Implant Direct Sybron International LLC$316K
Envista Holdings Corporation$82K
Straumann USA LLC$48K
Vatech America, Inc.$17K
Zimmer Biomet$9K
Zest Holdings, LLC$2K
plus $3K from 9 others

What the payments were for

Speaking & faculty fees$421,11288%
Travel & lodging$35,2047%
Food & beverage$9,7892%
Education$11,0362%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Implant Direct Sybron International LLC	103	$315,656
Envista Holdings Corporation	10	$82,374
Straumann USA LLC	7	$48,188
Vatech America, Inc.	12	$16,600
Zimmer Biomet	7	$8,549
Zest Holdings, LLC	2	$2,305
Salvin Dental Specialties, Inc.	6	$1,612
Zimvie Inc.	12	$902
Nobel Biocare USA	11	$694
3M Company	5	$101
Geistlich Pharma, North America, Inc.	1	$61
Align Technology, Inc.	3	$47
Carestream Dental, LLC	1	$22
Kerr Corporation	1	$16
Philips North America LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$477,142 in reported general payments places this provider in the 95th percentile of 5,764 general practice providers in New York.

See all general practice providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	40	$83
Ibuprofen	28	$62
Amoxicillin	16	$25

Paid to pharmacies, not to this prescriber.

Other general practice in Utica

Mark HochmanHicksville$5.1M
David RiceEast Amherst$1.2M
Ronnie MyersNew York$464K
Ira LangsteinWhite Plains$422K
Benedict MiragliaMount Kisco$378K
Michael MashaalRoslyn$262K
Michael DanielakBuffalo$197K
William RomeroDix Hills$197K
Alejandra Gonzalez-DuarteNew York$183K
Stuart DitchekBrooklyn$171K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →